Friday, August 14, 2020

COVID-19 vaccine: Aurobindo Pharma expects phase-I, II trials by end of 2020

COVID-19 vaccine: Aurobindo Pharma expects phase-I, II trials by end of 2020 Managing Director of Aurobindo Pharma, Narayanan Govindarajan in the recently held earnings call with analysts said the city-based pharma major has earmarked USD 150-200 million towards capex during the current fiscal.

from Moneycontrol Business News https://ift.tt/3iIjqGC
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Bajaj Auto shares fall 2% as firm, subsidiary fall prey to ransomware attack

Bajaj Auto shares dipped 2% following a ransomware attack on its systems and subsidiary, Bajaj Auto Technology Ltd, on June 23, 2026. The co...